Enzo Biochem Company Insiders

ENZ Stock  USD 1.13  0.02  1.74%   
Enzo Biochem's insiders are aggressively buying. The analysis of insiders' sentiment of trading Enzo Biochem stock suggests that vertually all insiders are extremely bullish at this time. Enzo Biochem employs about 179 people. The company is managed by 25 executives with a total tenure of roughly 166 years, averaging almost 6.0 years of service per executive, having 7.16 employees per reported executive.
Elazar Rabbani  Chairman
Chairman of the Board, Chief Executive Officer, Secretary
Bruce Dey  President
Vice President - Sales and Marketing of Enzo Clinical Labs

Enzo Biochem's Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2023-02-13James G WolfAcquired 5000 @ 1.28View
2023-02-10James G WolfAcquired 5000 @ 1.29View
2023-01-27James G WolfAcquired 11800 @ 1.4View
2022-11-23Hamid ErfanianAcquired 100000 @ 1.97View
2022-07-15Kara CannonAcquired 2500 @ 2.42View
2022-07-12Bradley Louis RadoffAcquired 12500 @ 2.27View
2022-07-05Bradley Louis RadoffAcquired 120000 @ 2.2View
2022-06-15Hamid ErfanianAcquired 4600 @ 2.19View
2022-06-14David BenchAcquired 3500 @ 2.15View
Monitoring Enzo Biochem's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Enzo Biochem Management Team Effectiveness

The company has Return on Asset of (0.1653) % which means that on every $100 spent on assets, it lost $0.1653. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4501) %, meaning that it generated no profit with money invested by stockholders. Enzo Biochem's management efficiency ratios could be used to measure how well Enzo Biochem manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Enzo Biochem's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.20 in 2024, despite the fact that Return On Capital Employed is likely to grow to (0.33). At this time, Enzo Biochem's Non Current Assets Total are fairly stable compared to the past year. Other Current Assets is likely to rise to about 2.8 M in 2024, whereas Total Assets are likely to drop slightly above 100.7 M in 2024.
Net Income Applicable To Common Shares is likely to rise to about 19.2 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 36.9 M in 2024.

Enzo Biochem Workforce Comparison

Enzo Biochem is rated below average in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 215,088. Enzo Biochem adds roughly 179 in number of employees claiming only tiny portion of equities under Health Care industry.

Enzo Biochem Profit Margins

The company has Net Profit Margin of 0.99 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.26) %, which entails that for every $100 of revenue, it lost $0.26.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.610.43
Significantly Up
Slightly volatile

Enzo Biochem Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Enzo Biochem insiders, such as employees or executives, is commonly permitted as long as it does not rely on Enzo Biochem's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Enzo Biochem insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Enzo Biochem Notable Stakeholders

An Enzo Biochem stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Enzo Biochem often face trade-offs trying to please all of them. Enzo Biochem's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Enzo Biochem's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Hamid ErfanianChief Executive Officer, DirectorProfile
Elazar RabbaniChairman of the Board, Chief Executive Officer, SecretaryProfile
Bruce DeyVice President - Sales and Marketing of Enzo Clinical LabsProfile
David BenchChief Financial Officer, Senior Vice President, Treasurer, Corporate SecretaryProfile
Paul OBrienVice President - Global Human ResourcesProfile
Barry WeinerPresident, Chief Financial Officer, Principal Accounting Officer, Treasurer, DirectorProfile
Herbert BassVice President - FinanceProfile
James OBrienExecutive Vice President - FinanceProfile
Mary TagliaferriLead Independent DirectorProfile
Dov PerlyskyLead Independent DirectorProfile
Ian WaltersIndependent DirectorProfile
Gregory BortzLead Independent DirectorProfile
Bernard KastenLead Independent DirectorProfile
Bruce HannaIndependent DirectorProfile
Dieter SchapfelChief Medical Director of Enzo Clinical LabsProfile
David GoldbergVP of Corporate Devel. and General Manager of Enzo Clinical LabsProfile
Dieter MDChief LabsProfile
Matthew KupferbergGeneral SecretaryProfile
Rebecca FischerIndependent DirectorProfile
Steve AnrederIR Contact OfficerProfile
Peter ClemensDirectorProfile
Patricia CPAInterim OfficerProfile
Fabian BlankDirectorProfile
Bradley RadoffIndependent DirectorProfile
Kara CannonCorporate Vice President - Commercial OperationsProfile

About Enzo Biochem Management Performance

The success or failure of an entity such as Enzo Biochem often depends on how effective the management is. Enzo Biochem management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Enzo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Enzo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.19  0.20 
Return On Capital Employed(0.35)(0.33)
Return On Assets 0.19  0.20 
Return On Equity 0.23  0.24 
The data published in Enzo Biochem's official financial statements usually reflect Enzo Biochem's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Enzo Biochem. For example, before you start analyzing numbers published by Enzo accountants, it's critical to develop an understanding of what Enzo Biochem's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Enzo Biochem's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Enzo Biochem's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Enzo Biochem's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Enzo Biochem. Please utilize our Beneish M Score to check the likelihood of Enzo Biochem's management manipulating its earnings.

Enzo Biochem Workforce Analysis

Traditionally, organizations such as Enzo Biochem use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Enzo Biochem within its industry.

Enzo Biochem Manpower Efficiency

Return on Enzo Biochem Manpower

Revenue Per Employee173.5K
Revenue Per Executive1.2M
Net Income Per Employee113.3K
Net Income Per Executive811.5K
Working Capital Per Employee326.6K
Working Capital Per Executive2.3M
When determining whether Enzo Biochem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enzo Biochem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enzo Biochem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enzo Biochem Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Enzo Stock analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Enzo Biochem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enzo Biochem. If investors know Enzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enzo Biochem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.47)
Revenue Per Share
0.657
Quarterly Revenue Growth
0.138
Return On Assets
(0.17)
Return On Equity
(0.45)
The market value of Enzo Biochem is measured differently than its book value, which is the value of Enzo that is recorded on the company's balance sheet. Investors also form their own opinion of Enzo Biochem's value that differs from its market value or its book value, called intrinsic value, which is Enzo Biochem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enzo Biochem's market value can be influenced by many factors that don't directly affect Enzo Biochem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enzo Biochem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzo Biochem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzo Biochem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.